Which of the following BEST defines the Drug Enforcement Agency?
A. The federal law enforcement agency responsible for the identification and control of drug use, abuse, and smuggling in the United States
B. Developed in 1996, a set of guidelines intended to reduce incorrect coding and improper overpayments or underpayments through the identification of codes that may or may not be utilized together or that are medically unlikely
C. The official standardized claim form that must be completed and utilized when submitting any Medicare or Medicaid claim
D. A unique number required by Medicare to identify each individual qualified healthcare provider and each individual healthcare organization; must be used when reporting any healthcare service that has been performed by the individual provider and/or healthcare organization
Question 2
Which of the following BEST defines the national provider identifier?
A. A unique number required by Medicare to identify each individual qualified healthcare provider and each individual healthcare organization; must be used when reporting any healthcare service that has been performed by the individual provider and/or healthcare organization
B. The federal law enforcement agency responsible for the identification and control of drug use, abuse, and smuggling in the United States
C. Developed in 1996, a set of guidelines intended to reduce incorrect coding and improper overpayments or underpayments through the identification of codes that may or may not be utilized together or that are medically unlikely
D. The official standardized claim form that must be completed and utilized when submitting any Medicare or Medicaid claim
Buccal drug administration
Single-dose drug administration: pharmacokinetic values for this drug are as follows: onset of actio
The Three Names Given to a Drug
Effect of pH on drug absorption: (a) A weak acid such as aspirin (ASA) is in a nonionized form in an ...
If drug elimination mechanisms become saturated, a drug may exhibit zero-order elimination.
Clinically Significant Drug-Disease Interactions in Dentistry